Skin reactions after intramuscular injection of Botulinum toxin A: A rare side effect [7]

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 79, Issue 2, 2008, Pages 231-232

  Brueggemann, N ^a   Doegnitz, L ^b   Harms, L ^c   Moser, A ^a   Hagenah, Johann M ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b Jewish Hospital Berlin   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADULT; CASE REPORT; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEMIPARESIS; HUMAN; INJECTION SITE REACTION; LETTER; LONG TERM CARE; MALE; MUSCLE SPASM; PRICK TEST; PRIORITY JOURNAL; SKIN MANIFESTATION; STROKE; DRUG ERUPTION; INTRAMUSCULAR DRUG ADMINISTRATION; MIDDLE AGED; RETREATMENT; SPASTICITY;

BOTULINUM TOXIN TYPE A; DRUG ERUPTIONS; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; MUSCLE SPASTICITY; RETREATMENT;

EID: 38849166078     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2007.130138     Document Type: Letter

References (6)

1. Bowden JB, Rapini RP. Psoriasiform eruption from intramuscular botulinum A toxin. Cutis 1992;50:415-6.
2. Li M, Goldberger BA, Hopkins C. Fatal case of BOTOX-related anaphylaxis? J Forensic Sci 2005;50:169-72.
3. Coombs RRA, Geu PGH. Classification of allergic reactions responsible for drug hypersensitivity reactions. In: Coombs RRA, Geu PGH, eds. Clinical Aspects of Immunology. 2nd edn. Philadelphia, PA: Blackwell Scieice Ltd., 1968:575-96.
4. Schellekens H. Factors influencing the immunogenicity of therapeutic proteins. Nephrol Dial Transplant 2005;20(Suppl 6):vi3-9.
5. Mezaki T, Sakai R. Botulinum toxin and skin rash reaction. Mov Disord 2005;20:770.
6. LeWitt PA, Trosch RM. Idiosyncratic adverse reactions to intramuscular botulinum toxin type A injection. Mov Disord 1997;12:1064-7.